Prevention of Acute Exacerbation in Subjects with Moderate-to-very Severe COPD by Modulating Lower Respiratory Microbiome: Protocol of a Prospective, Multicenter, Randomized Controlled Trial.

Hua, Jian-Lan; Hu, Wei-Ping; Zuo, Yi-Hui; Zhang, Jing

Hua, Jian-Lan; Hu, Wei-Ping; Zuo, Yi-Hui; Zhang, Jing.

Afiliação

Hua JL; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Hu WP; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Zuo YH; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.
Zhang J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

Int J Chron Obstruct Pulmon Dis ; 15: 2985-2990, 2020.

Article em En | MEDLINE | ID: mdl-33235447

Assuntos

Microbiota; Doença Pulmonar Obstrutiva Crônica; Progressão da Doença; Humanos; Estudos Multicêntricos como Assunto; Estudos Prospectivos; Doença Pulmonar Obstrutiva Crônica/diagnóstico; Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico; Qualidade de Vida; Ensaios Clínicos Controlados Aleatórios como Assunto

Palavras-chave

amikacin; chronic obstructive pulmonary disease; probiotics; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Microbiota Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google